(Total Views: 548)
Posted On: 10/04/2024 10:10:16 AM
Post# of 148870
Re: HHIGambler #146875
Quote:
I suspect they heard back from the FDA and that is why they moved forward with engaging Syneos as the CRO at this time.
I wish this were so, HHi, but if I were writing today's PR I would have mentioned that the protocol had already been accepted instead of saying this:
Quote:
As previously announced, the Company’s final study protocol was submitted to the FDA for approval in September 2024, and CytoDyn expects to start screening patients in early 2025.
(7)
(0)Scroll down for more posts ▼
